Return to content in this issue


Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis

Freemantle N1, Piketty C2

1Institute of Clinical Trials and Methodology, University College London, London, UK
2Galderma, Lausanne, Switzerland

J Investig Allergol Clin Immunol 2021; Vol 31(6) : 528-529
doi: 10.18176/jiaci.0727

Key words: Nemolizumab, Adult atopic dermatitis